High mortality rate from bronchitis is escalating the US bronchitis treatment market

US bronchitis treatment market is projected to grow at a significant CAGR of around 2.4% during the forecast period (2020-2026). The market for bronchitis treatment in India is driven by the rising incidence and mortality rate of bronchitis in the country. According to the Centers for Disease Control and Prevention (CDC), in the US states with the highest,  mortality rate from the chronic lower respiratory disease are West Virginia (64.3%), Oklahoma (63.5%), Kentucky (62.1%), Arkansas (61.7%), and Mississippi (59.9%). Though, the highest mortalities were registered in California (13,634 mortalities with 30.9% mortality rate), Florida (12,362 mortalities with 37.0% mortality rate), Texas (10,766 mortalities with 39.7% mortality rate), Ohio (7,518 mortalities with 49.0% mortality rate), and New York (7,270 mortalities with 28.5% mortality rate).

• Number of adults with diagnosed chronic bronchitis in 2018: 9.0 million
• Percent of adults with diagnosed chronic bronchitis in 2018: 3.6%

Bronchitis (chronic and unspecified) mortalities

• Number of mortalities: 492
• Deaths per 100,000 population: 0.2

Browse the full report description US Bronchitis Treatment Market Size, Share & Trends Analysis Report by Type (Drugs (Antibiotics, Anti-Inflammatory Drugs, Bronchodilators, and Others) and Oxygen Therapy) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/us-bronchitis-treatment-market

There are several research organizations in the US that are engaged in the development of effective treatment solution for the chronic lung disorders. Bronchitis is one among the major lung disease that is being studied in the healthcare research organization in the country. Along with the research organizations, there are several market players headquartered in the US, such as Abbott Laboratories and Pfizer Inc.

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in base year?
• Which segment will project fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?

o Recovery Timeline

o Deviation from pre-COVID 

o Most affected segment

o Recommendations 

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

US Bronchitis Treatment Market – Segmentation

By Technology

• Medication 

o Antibiotics

o Anti-inflammatory drugs

o Bronchodilators

o Others (Mucolytics) 

• Oxygen Therapy